CONGRESS

PARIS
17-20 SEPT 2025

Sessions

Industry sessions

The EADV industry partners organize several sessions as an adjunct to the EADV scientific sessions. The sessions are organized by the companies and feature presentations by experts in the field, panel discussions and other type of sessions.

Industry session types

The industry sessions are a valuable way to learn about new research, techniques or treatments in the field of dermatology and venereology. In addition, some sessions will focus on sharing information about new products, services and/or technologies available.

At the EADV Congress, two different types of industry sessions are organized:

Satellite Symposia

Satellite symposia are organized in the main session rooms and take place during the morning, lunch and in the evening, after the last scientific sessions. These sessions last between 45, 60 and 90 minutes and offer a wider education on the presented topic to remain updated on any progression in the field.

Industry Expert Hubs

Industry expert hubs are organized in Pavillion 7.2.1 (level 2) of the Paris Expo Porte de Versailles. These sessions last 45 minutes and are focused on bringing together a smaller group of experts to discuss more in-depth or to focus on a specific topic.

The session programme will be published here as soon as available.

The industry session organiser is solely responsible for keeping any of its industry sessions activities compliant with all relevant laws and regulations. EADV is not involved with in or have any control over the content, quality, organization, operation, scientific integrity of the activity and materials. EADV will not be involved in the selection of speakers, moderators and other faculty.

As a multidisciplinary audience will be attending the EADV Congress 2025, please make sure to select the right category, healthcare professionals (HCPs) and non-healthcare professionals (NON-HCPs), during the registration process.

Access to any industry sessions where data or research of prescription medicines is presented will be limited exclusively to healthcare professionals (HCPs) only and Non Members (INDUSTRY).

Industry session organisers may limit participation to certain representative groups independently from EADV recommendations if deemed imperative to the achievement of the intended purpose of the Industry session.

Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).

The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:

AIM Group International – AIM Education S.r.l.

Cristina Ghidoli
Via G. Ripamonti, 129
20134 Milan, Italy

Tel. +39 02 56601.1
e-mail: [email protected] – [email protected]

Industry sessions programme

The session programme will be published here as soon as available.

The industry session organiser is solely responsible for keeping any of its industry sessions activities compliant with all relevant laws and regulations. EADV is not involved with in or have any control over the content, quality, organization, operation, scientific integrity of the activity and materials. EADV will not be involved in the selection of speakers, moderators and other faculty.

Access to the industry sessions

As a multidisciplinary audience will be attending the EADV Congress 2025, please make sure to select the right category, healthcare professionals (HCPs) and non-healthcare professionals (NON-HCPs), during the registration process.

Access to any industry sessions where data or research of prescription medicines is presented will be limited exclusively to healthcare professionals (HCPs) only and Non Members (INDUSTRY).

Industry session organisers may limit participation to certain representative groups independently from EADV recommendations if deemed imperative to the achievement of the intended purpose of the Industry session.

Official Italian Agency for AIFA Procedure

Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).

The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:

AIM Group International – AIM Education S.r.l.

Cristina Ghidoli
Via G. Ripamonti, 129
20134 Milan, Italy

Tel. +39 02 56601.1
e-mail: [email protected] – [email protected]

Don’t hesitate to contact us for more information – [email protected]

European Academy of Dermatology and Venereology - Logo Red
Facebook Instagram Linkedin Spotify Youtube
Contact
Imprint & Privacy policy
EADV Team
Cookie policy
CAREERS
Terms of use

Only trust information from our official website: eadv.org | Copyright 2024 EADV

HEALTHCARE PROFESSIONAL DEFINITION

Important note to Healthcare and Non-Healthcare Professionals

Access to the different areas and sessions of the Congress depends on the status. Please read the description below to ensure you/your delegates comply with the regulations in place.
EADV Members are not designated as Healthcare Professionals by default. Please attribute the correct status (HCP or Non-HCP) during registration.

Definition

A multidisciplinary audience will attend the EADV Congress, and the EADV will assign different classes to healthcare professionals (HCP) and non-Healthcare Professionals (non-HCP) to ensure compliance with these regulations.

Chapter 3 of the Dutch CGR code defines HCPs as follows:
“3.1 In the purpose of this Code of Conduct, the following terms shall bear the following meaning:
healthcare professionals: persons qualified to prescribe or supply prescription-only medicinal products.”

Further explanation is provided in The General information about organising scientific meetings and Frequently Asked Questions from the CGR (Dutch Foundation for the Code for Pharmaceutical Advertising (to be referred to as the general information document from here on out) (20170214 CGR informatie congresorganisaties), where it states (at section 2 a, page 2) that: “In the Netherlands the group of healthcare professionals comprises: physicians, physicians who are being trained to become a specialist (‘artsen in opleiding’), pharmacists, pharmacist’s assistants, obstetricians, dentists, physician assistants, nurse practitioners and specialised nurses.”

Dutch Nurses, in Particular

It further clarifies that:
… “Specialised nurses (limited to the lung, diabetes and oncology areas) only have independent prescription authority if they have completed a specific training programme for this purpose. The completion of this training is entered in the BIG register and so can be checked by anyone. This means that all of the other healthcare providers, such as regular nurses, dieticians, dental hygienists or supportive GP practitioners (‘praktijkondersteuners’), are not healthcare professionals and so – just like patients – belong to the ‘general public’. This group will be referred to below as ‘non-healthcare professionals’.”

In terms of specialised nurses, the explanatory notes to the CGR code (20200701 Explanatory Notes CGR per 20200701) provide a specific list to be taken into consideration:

3.1.d Definition of “healthcare professional”
…. pharmacist’s assistants and nurses with the additional BIG registrations:

Specialised nurses (gespecialiseerd verpleegkundigen):

  • Diabetes nurses
  • Pulmonary care nurses
  • Oncology nurses

Specialised nurses may only be considered as healthcare professionals if their BIG registration states that they have prescription authority. ….
Nurse specialists (NS) (verpleegkundig specialisten):

  • NS providing general healthcare
  • NS providing mental healthcare“

Residents

Lastly, the explanatory notes state (at page 3) that:
“Physicians in training to become a specialist (artsen in opleiding) are also considered as healthcare professionals within the meaning of the Code of Conduct. Medical students are not considered healthcare professional (see Newsletter 2006/4).”

Other Categories

The general information document (sections 2d and e, page 3) goes on to clarify that industry employees and specialised journalists can be exposed to promotional content. Yet patients, patient representatives, and regular press or specialised journalists who target the general public will still be considered non-HCPs and should not be exposed to promotional content.
STUDENTS are NOT considered as Healthcare Professionals under the current guidelines and will be automatically classified as NON-HEALTHCARE PROFESSIONALS.

Industry sessions

Satellite Symposia and Industry Hub Sessions presenting data on the development, research, or other issues related to prescription medicine is restricted to Healthcare Professionals and Industry Participants as indicated by the Industry Session Organizer. All promotional materials and marketing aids related to these industry sessions should be strictly limited to HCPs. Industry Session organisers can limit participation to certain representative groups independently from the EADV recommendations if deemed imperative to achieving the session’s intended purpose. The organising company reserves the right to refuse single categories, particularly if they are not adequately related to the session’s objective and purpose.

The industry session organiser is responsible for compliance with the session.